Impact of cetuximab plus cisplatin alone and cetuximab plus cisplatin and paclitaxel regimen on humanistic outcome in head and neck cancer

Impact of cetuximab plus cisplatin alone and cetuximab plus cisplatin and paclitaxel regimen on humanistic outcome in head and neck cancer

Abstract Background The prevalence of head and neck cancer (HNC) is increasing rapidly, and the prognosis is poor in the advance stage. For the patient suffering from advance stage HNC, the improvement in quality of life and decrease mortality remain as the mainstay of treatment. The aim was to asse...

Full description

Bibliographic Details
Main Authors: Avinash Khadela, Bhavin Vyas, Mustakim Mansuri, Dipen Sureja, Kunjan Bodiwala
Format: Article
Language:English
Published: SpringerOpen 2023-01-01
Series:Journal of the Egyptian National Cancer Institute
Subjects:
Head and neck cancer
Quality-adjusted life-years
Cetuximab
Cisplatin
Paclitaxel
Recurrent or metastatic head and neck squamous cell carcinoma
Online Access:https://doi.org/10.1186/s43046-023-00160-9

Internet

https://doi.org/10.1186/s43046-023-00160-9

Similar Items